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1. Introduction 
Martinez-Carrion etal. [1] have shown that cyto- 
plasmic aspartate aminotransferase contains three or 
more forms, indicated by ct,/3, 7, according to their 
increasing electrophoretic mobility. These multiple 
forms have a very similar structure [2-4] and differ 
by their catalytic activity. 
The present work shows that the multiple forms 
are not due to the binding of some ligand, nor the 
aggregation or dissociation of subunits. They behave as 
"conformers" irreversibly produced after the oxida- 
tion of some SH residues and their formation can be 
prevented by thiol protecting reagents. 
2. Materials and methods 
Aminoacids, a-ketoacids and DTT are Calbiochem 
A grade reagents, urea is a Merck product for bio- 
chemistry and DTNB an Aldrich product. Cytoplas- 
mic AAT is prepared from pig heart by the method of 
Jenkins, Yphantis and Sizer [5], using succinate in- 
stead of maleate. The multiple forms are separated by 
electrofocusing on ampholine L.K.B. at pH 5 to 7, 
the method used is very similar to that described by 
Marino [6]. The identification of the subforms is 
performed by electrophoresis onpolyacrylamide g l; 
the gels are stained either with amino black 10 B to 
Abbreviations: 
DTT : dithiothreitol; 
DTNB : 5-5 '-dithiobis-2-nitribenzoate; 
AAT : L-aspartate aminotransferase (L-aspartate~2-oxo- 
glutarate aminotransferase, EC 2.6.1.1). 
determine protein or by aspartate, t~-ketoglutarate 
and azoene fast violet B to determine the aspartate 
transaminase activity [7]. The molecular weights on 
the gels are determined by the method of Hedrick 
and Smith [8] serumalbumin a d ovalbumin are used 
as standards. The AAT concentrations are determined 
by absorbance at280 nm; we have found an e280n m 
value of 135,000 for the holoenzyme and 128,000 for 
the apoenzyme, this value refers to dimeric enzyme of 
molecular weight 90,000. The enzymatic activities are 
determined with L-aspartate 2 X 10 -2 M and ct-keto- 
glutarate 2 × 10 -3 M (maximum velocity conditions); 
the oxaloacetate formed is measured either by absorb- 
ance at 280 nm or by NADH and malate dehydrogen- 
ase. 
3. Results and discussion 
The hypothesis that the subforms are due to the 
binding of ligand or to the aggregation or dissociation 
of subunits can be eliminated. Indeed, we observe that 
the deionization of a mixture of or,/3, and 3' forms by 
chromatography onDowex 50 H form and Amberlite 
IRA 400 OH form in mixed bed gives the spectral 
change described by Bergami [9] without change in 
the subform composition, and that the apparent 
molecular weight obtained on the acrylamide gel by 
the method of Hedrick and Smith [8] is the same for 
all the forms: about 60,000. 
The last hypothesis that the multiple forms are 
"conformers" [10, 11]. This fact is confirmed by aging 
[3] and urea effect. 
A mixture of a,/3, and ? forms is treated for one 
hr by 8 M urea at pH 8.5 (enzyme 10 -6 M). Much of 
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Table 1 
Results of the treatment of a mixture of or,/3, 3' forms by urea and DTT. 
November 1970 
Treatment Effect (analyzed after elimination of the reagents) 
at pH 8.3 
(0t,/3, 7) Subforms Activity SH titratable 
( V m arbitrary units) by DNTB 
SH residual 
titratable by pMB 
- a ,  ~3, 3', 100a 3.9 b 4 
Urea 8 M ot ~, j3 ~ ,,/ 80c N.D. N.D. 
Urea 8 M + DTT 10 -3 M no change 100 N.D. N.D. 
DTT 5 X 10 -2 M (at 4 °) 
3 hr no change 5.7 4 
18 hr no change 100 6.1 4 
DTT5X 10 "2M+urea8M 
18 hr at 4 ° no change 100 5.3 d 4 
a O~ and # forms, prepared by electrofocusing, have almost he same activity. 
b This value is variable with time and varies in different preparations (4.7 to 3). 
c This value decreases with incubation time. 
d Bad imprecision due to some light scattering. 
N.D. = not determined. 
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Fig. 1. Electrophoresis on polyacrylamide g l at pH 8.1 of 
aspaxtate aminotransferase, 0t form. 
a) initial enzyme; 
b) enzyme after treatment by 8 M urea; 
c) enzyme after treatment by 8 M urea and DTT 10 -3 M. 
The results are the same for the specific coloration and for 
the protein coloration. 
the protein precipitates after dialyses and concentra- 
tion by ultrafi ltration; the soluble protein is richer 
in/5 and "t forms than the initial mixture. This treat- 
ment is repeated on an almost pure a form. The same 
quantity of protein is analysed before and after the 
treatment. According to fig. 1, electrophoresis shows 
that a form is transformed to ]3 and 3' forms and that 
some polymerized and non-migrating material, with 
transaminase activity, is formed. These results indicate 
a transformation ot ~ ]3 ~ "r -~... As it is known that 
some of the SH residues of the enzyme, titratable 
either by iodoacetate [12] or by DTNB [13] are 
easily oxidizable, another urea treatment has been 
performed in the presence of SH protecting reagents, 
mercaptoethanol 10"1 M or DTT 10 .3 M: no change 
is observed in the subform composit ion (fig. 1), the 
enzymatic activity remains constant and at pH 4.5 
there is no change in the coenzyme absorption at 430 
nm. The thiol protecting reagents prevent he fc~rma- 
t ion of  mult iple forms and the irreversible inactivation 
that are induced by urea. 
If it is assumed that aging proceeds by the same 
mechanism as the urea effect, perhaps the thiol re- 
agents can prevent he aging effect. AAT is prepared 
with DTT 10 .4 M containing reagents, as soon as 
possible after the death of the pigs: the obtained 
enzyme is almost pure a form. We also try to reverse 
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Fig. 2. Scheme of formation of the multiple forms. 
the forms to a form, with unfolding and reducing 
reagents. A mixture of a,  ~ and 3' forms is treated by 
DTT and urea. For each assay the autoxidizable SH 
groups are titrated with DTNB after elimination of 
the reagents by filtration on Sephadex G 25 and it is 
verified that there are always four residual SH groups 
titratable by pMB [13]. For a native holoenzyme 
these residual SH groups can be titrated in about 17 
hr [13] without addition ofurba [14], the effect of 
urea being only to accelerate the titration rate. The 
results are summarized in table 1 : DTT treatment 
can reverse the oxidation of  the SH, but the unfolding 
effect of urea is insufficient o reverse the forms to 
the a form. 
The multiple forms of  cytoplasmic AAT behave as 
conformers irreversibly formed. The primary step is 
monitored by SH oxidation and one can propose the 
following scheme of formation (fig. 2). 
The group indicated as XH is that postulated by 
Banks [3], this group comes in more intimate contact 
with the solvent when ~, 3' are formed. 
From a practical point of  view, if only the a form 
is to be prepared, the use of DTT 10 .4 M allows one 
to avoid the chromatography on CM Sephadex or the 
electrofocusing. 
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